Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot study. [electronic resource]
Producer: 20120302Description: 1005-16 p. digitalISSN:- 0394-6320
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- immunology
- Chemotherapy, Adjuvant
- Chi-Square Distribution
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Feasibility Studies
- Female
- Humans
- Immunotherapy -- adverse effects
- Interleukin-2 -- adverse effects
- Italy
- Kaplan-Meier Estimate
- Leukapheresis
- Leukocytes, Mononuclear -- immunology
- Lung Neoplasms -- immunology
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Pilot Projects
- Pneumonectomy
- Proportional Hazards Models
- Recombinant Proteins -- therapeutic use
- Survival Rate
- Time Factors
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.